DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose

PHASTAR Names Chris Schoonmaker as Chief Operations Officer

London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience. 

mdgroup appoints LaQuinta Jernigan as Chief Operating Officer

Executive leadership appointment to drive seamless client experiences in patient- servicing and digitally enabled clinical trials

mdgroup recognised as one of the UK's fastest-growing private companies

9 June 2022 - Bracknell, UK: mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management

LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm.  The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.